SS

Sekhar Shreeranjani

Active Director Director DIN 10912856
DIN 10912856 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sekhar Shreeranjani

Data last updated:

Sekhar Shreeranjani is a Director at Visionex Pharma Private Limited (since 2025). The company operates in Paper.

DIN 10912856
Primary Designation Director
Industry Paper
First Appointment 20 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Visionex Pharma Private Limited U21000TN2025PTC176231
Director20 Jan 20252025Active

Board colleagues of Sekhar Shreeranjani

NameDINCompanyDesignation
Jayasuriya Subramani08593432Visionex Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Visionex Pharma Private Limited
Premium access

Shareholding and investment profile for Sekhar Shreeranjani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekhar Shreeranjani

Sekhar Shreeranjani currently holds 1 directorship: Visionex Pharma Private Limited (Director, since 20 Jan 2025).

Sekhar Shreeranjani was first appointed on 20 Jan 2025 as Director at Visionex Pharma Private Limited.

The current boards of Sekhar Shreeranjani's companies include Jayasuriya Subramani (Visionex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available